Procentdelen af patienter med D - vitaminmangel (serum 25- hydroxyvitamin D ≤ 22, 5 nmol/ l [≤9 ng/ ml]) var signifikant reduceret med 92% med FOSAVANCE (70 mg/ 2800 IE) versus alendronat alene (henholdsvis 1% versus 13%).
The percentage of patients with vitamin D deficiency (serum 25- hydroxyvitamin D <  22.5 nmol/ l [<  9 ng/ ml]) was significantly reduced by 92% with FOSAVANCE (70 mg/ 2800 IU) vs. alendronate-only (1% vs 13%, respectively).